We provide you with 20 years of free, institutional-grade data for ADVM stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ADVM. Explore the full financial landscape of ADVM stock.
| Reported Date | CIK | Ticker | Type |
|---|
Adverum Biotechnologies, Inc(NASDAQ:ADVM) 
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal dis...
Website: http://www.adverum.com
Founded: 2006
Full Time Employees: 114
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about ADVM stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.